Workshop
Clinical Trials Essentials: An Intensive One-Week Course (Register for full week or 4-hr sessions)
Speakers:
Edward Rozhon, Mike Huston, Pete Shabe, Savita Sinha, Clarisa Tate, Narinder Singh, Frances Ann McKenney
Organizers:
Date:
2016-03-14
Time:
12:30-17:00 Pacific Time
Registration fee:
(USD): One-week full course (unemployed): $925; One-week full course: $1865; Mon AM: Drug Development Process: $250; Mon PM: Science of Clinical Trials Design: $250; Tue AM: Clinical Data Management: $250; Tue PM: Applied Statistics in Clinical Trials; Study Site Perspective: $250; Wed AM: Monitoring Clinical Trials: $250; Wed PM: Medical Devices, An Overview: $250; Thur AM: GCP & ICH Investigator & Clinical Research Site: $250; Thur PM: Clinical QA/Compliance Audits and the FDA: $250; Good Manufacturing Practices and regulatory trends: $250; Fri PM: Global Clinical Trials Perspective; Business of Clinical Research: $250
Location:
SF Bay Area: Foster City Crowne Plaza
Major Sponsor:
Vendor show vendors registered to date:
Registration: http://www.PBSS.org
Registration deadline:2016-03-10
(it will close sooner if the seating cap is reached)
About the Topic
Clinical Trials Essentials: An Intensive One-Week Course
A joint course between UCSC Extension Silicon Valley and
Pharmaceutical & BioScience Society -- San Francisco Bay
March 14-18, 2016
(Register for the full-week or any half-day sessions)
Monday March 14, 2016 – 8:30 am—12:30 pm
Drug Development Process 4 hours – Edward Rozhon
- Major players in drug development
- Assay development and discovery of new medical entities
- Non clinical and clinical development of new drugs
- History and regulatory oversight of FDA
- Structure of Phase I, II, & III clinical trials
- FDA review of New Drug Application
Monday March 14, 2016 – 1:30 pm—5:30 pm
Science of Clinical Trials Design 4 hours – Mike Huston
- Phases of drug development
- Objectives of clinical studies
- Basic clinical trials designs
- Underlying science for clinical trials designs
Tuesday March 15, 2016 – 8:30 am—12:30 pm
Clinical Data Management 4 hours – Gerri O’Riordan
- Translational research in an academic center: fundamental strengths and weaknesses
- Research Process and Operations management as the success of a trial
- Essential conversations between academia, biomedical and pharmaceutical companies, venture capitalists and consultants
- Data Integrity and well-supported metrics (Case Studies)
Tuesday March 15, 2016 – 1:30 pm—3:30 pm
Business of Clinical Research 2 hours – Mike Huston
- The Market Players – Pharma, Biotech, Contract Research Organizations (CROs)
- Cost of Doing Business – Cost of conducting clinical research
- Outsourcing and CROs – It costs money to make money
- Innovative Ways to Reduce Cost – Business Strategies and Process Innovations.
Tuesday March 15, 2016 – 3:45—5:30 pm
Study Site Perspective 2 hours – Speaker TBA
- Translational research in an academic center: fundamental strengths and weaknesses
- Research Process and Operations management as the success of a trial
- Essential conversations between academia, biomedical and pharmaceutical companies, venture capitalists and consultants
- Data Integrity and well-supported metrics (Case Studies).
Wednesday March 16, 2016 – 8:30 am—12:30 pm
Monitoring Clinical Trials 4 hours – Savita O. Sinha
- Review the basic regulatory requirements of monitoring a clinical research study
- Describe the tasks that should be performed before, during, and after a monitoring visit
- Learn how to track all key parameters involved in monitoring a site
- Know how to complete visit reports and follow-up on action items after each site visit.
Wednesday March 16, 2016 – 1:30 pm—5:30 pm
Medical Devices, An Overview 4 hours – Clarisa Tate
- What is a medical device, an general overview of regulations
- Medical devices regulatory pathways: 510(k), PMA, and HDE
- Medical device clinical trials: Focus on Investigational Device Exemptions
- Post-market surveillance: Focus on 522, complaints, and recalls
- Globalization and changing regulatory environment.
Thursday March 17, 2016 – 8:30 am—12:30 pm
GCP & ICH Investigator & Clinical Research Site 4 hours – Narinder Singh
- Historical and legislative roads to Good Clinical Practices (GCP)
- Principles of GCP and the research-care conflict
- Role of various stakeholders in Clinical Trials
- Elements of informed consent.
Thursday March 17, 2016 – 1:30 pm—5:30 pm
Clinical QA/Compliance Audits and the FDA 4 hours – Frances Ann McKenney
- Qualifications needed for GXP auditors and FDA Inspectors
- Objectives of sponsor audits and regulatory inspections
- Similarities and differences between sponsor audits and regulatory inspections
- General approach to hosting an audit or inspection
- Types of findings that cause concern for auditors or inspectors.
Friday March 18, 2016 – 8:30 am—12:30 pm
Good Manufacturing Practices and regulatory trends 4 hours – Narinder Singh
- Good Manufacturing Practices (GMP) for drugs
- GMP for biologics and related products, including Good Tissue Practices
- Considerations for Quality Systems.
Friday March 18, 2016 – 1:30 pm—2:30 pm
Global Clinical Trials Perspective 1 hour -- Narinder Singh
- Trends in global clinical trials.
- Role of FDA and local regulatory culture.
Friday March 18, 2016 – 2:45 pm—5:30 pm
Applied Statistics in Clinical Trials 2 hours – Pete Shabe
- The role statistics plays in clinical research
- Basic data summarization techniques
- Estimation and Hypothesis Testing Introduction
- Estimation and Confidence Intervals
- Statistical Hypothesis Testing.
2024-10-25, [Free Online Workshop] Unleashing the Power of Real-World Evidence / Data (RWE/RWD) to Facilitate Drug Discovery, Development, and Beyond
|
2024-10-28, [Free Webinar] ASCO/ESMO Highlights: Latest Advances in Oncology Drug Development
|
2024-11-01, [In-Person] Clinical Pharmacology Studies on Hepatic and Renal Impairments for NDA Filing: Strategies, Design, Conduct, Analysis and Regulatory Aspects
|
2024-11-13, [Free Online Workshop] Career Transition for Research Scientists: Business Development & BioPartnering
|
2024-11-15, [In-Person] Current State of Bioanalysis for Biologics and Cell/Gene Therapy Products: Refining Established Approaches for New Complex Therapies
|
2024-12-05, [Free Online] Innovative Mass Spectrometry and Related Technologies for Life Science and Drug Development
|
2024-12-13, Why All These New Modalities?
|
2025-01-22, [In-Person] Small-Molecule Formulation for Discovery & Early Development (jointly by PBSS / AAPS-BADG / Syner-G)
|
2025-02-06, [In-Person] Intellectual Property (IP) Strategies and Best Practices
|
2025-02-26, [In-Person] Demystifying Biopharma Business Development
|
2025-03-07, [In-Person] Clinical Trial Planning and Conduct: Fundamentals, Strategies and Best Practices
|
2025-03-27, [Free Online Workshop] Biotech Financing 101: from Angels, Government Agencies, Foundations and VCs
|